Investing Acceleration of RAD204 Phase 1 dose escalation trial by admin May 12, 2025 May 12, 2025 Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com Email previous post Multiple New Multi-Commodity Targets next post Trump to sign executive order slashing drug prices today: Asian pharma stocks fall, analysts flag downsides You may also like Market Presentation June 18, 2025 Acquisition of Solar Panel Recycling Technology June 18, 2025 Resolution Minerals LtdTo Develop U.S. Government Engagement Strategy... June 18, 2025 Lithium Universe LtdAcquisition of Solar Panel Recycling Technology June 18, 2025 SPUT’s US$200 Million Uranium Buying Plan Spurs Market... June 18, 2025 Significant Uranium anomalies identified across the NT June 17, 2025 Jp Cortez: Is America’s Gold Really There? US... June 17, 2025 Mobile Gaming Stocks: 10 Biggest Companies in 2025 June 17, 2025 Critical One Sells Uranium Assets to Dark Star,... June 17, 2025 Burgum Endorses Colosseum Rare Earths Project in Continued... June 17, 2025